reference/32526578

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526578

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	905
issn	1470-2045
issueIdentifier	9
pageRange	897-905
publicationName	The Lancet. Oncology
startingPage	897
bibliographicCitation	Leboulleux S, Bastholt L, Krause T, de la Fouchardiere C, Tennvall J, Awada A, Gómez JM, Bonichon F, Leenhardt L, Soufflet C, Licour M, Schlumberger MJ. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial. Lancet Oncol. 2012 Sep;13(9):897–905. doi: 10.1016/s1470-2045(12)70335-2. PMID: 22898678.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8db14c123ba136d592ffef0875aed9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9882e758722b916a23462acb89076044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3edec6567d999cb34ee1bbd4fbfda143 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4131-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8b0090832fe95cfcffa6c0d2d53f430 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85c3873d517c929ab553366ddeb59ceb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dda2452629db8b0bb0bc12b3e1b21d94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_100fed24a630f62618cc4f34ca96b65f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9e03b4ab8c86251c7b5abd7d5a05a43 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8eed78f1170076509e452a7093cacfc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_762b080c65e2ab7f911da9ce58de189f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5236742449054a03b974c2bf5de3d02d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e39ee6de3feb5879e5f1a1d2f59644
date	201209
identifier	https://pubmed.ncbi.nlm.nih.gov/22898678 https://doi.org/10.1016/s1470-2045%2812%2970335-2
isPartOf	https://portal.issn.org/resource/ISSN/1470-2045 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27004
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
discusses	http://id.nlm.nih.gov/mesh/M0185203 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0421253 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010880Q000627 http://id.nlm.nih.gov/mesh/D013964Q000556 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D013964Q000188 http://id.nlm.nih.gov/mesh/D011799Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010880Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008207 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D018263 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D002277 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002291 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D012878Q000556 http://id.nlm.nih.gov/mesh/D013964Q000473 http://id.nlm.nih.gov/mesh/D000077273 http://id.nlm.nih.gov/mesh/D013964Q000401 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D011799Q000009 http://id.nlm.nih.gov/mesh/D003967Q000139 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006329Q000187 http://id.nlm.nih.gov/mesh/D004562Q000187 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D008175Q000556 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D040262Q000037
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9419 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8355 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733

Total number of triples: 84.